(Q47416647)

15 January 2018

title

Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera (English)

1 reference

15 January 2018

author name string

Marina Karakantza

1

1 reference

15 January 2018

Nikolaos C Giannakoulas

2

1 reference

15 January 2018

Panagiotis Zikos

3

1 reference

15 January 2018

George Sakellaropoulos

4

1 reference

15 January 2018

Alexandra Kouraklis

5

1 reference

15 January 2018

Anthi Aktypi

6

1 reference

15 January 2018

Ioannis C Metallinos

7

1 reference

15 January 2018

Eleni Theodori

8

1 reference

15 January 2018

Nicholas C Zoumbos

9

1 reference

15 January 2018

Alice Maniatis

10

1 reference

15 January 2018

publication date

1 April 2004

1 reference

15 January 2018

International Journal of Hematology

published in

1 reference

15 January 2018

volume

79

1 reference

15 January 2018

issue

3

1 reference

15 January 2018

page(s)

253-259

1 reference

15 January 2018

Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications

cites work

1 reference

12 December 2020

Increased platelet surface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia

1 reference

12 December 2020

Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera

1 reference

12 December 2020

Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.

1 reference

12 December 2020

In vivo platelet release in myeloproliferative disorders

1 reference

12 December 2020

Recent progress in the pathogenesis and management of essential thrombocythemia

1 reference

12 December 2020

Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF

1 reference

12 December 2020

Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

1 reference

12 December 2020

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia

1 reference

12 December 2020

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

1 reference

12 December 2020

Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.

1 reference

12 December 2020

Increased thromboxane biosynthesis in essential thrombocythemia.

1 reference

12 December 2020

Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients

1 reference

12 December 2020

Platelet and Plasma β Thromboglobulin in Mycloproliferative Syndromes and Secondary Thrombocytosis

1 reference

12 December 2020

Circulating activated platelets in myeloproliferative disorders

1 reference

12 December 2020

Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera

1 reference

12 December 2020

Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemia

1 reference

12 December 2020

Validated questionnaire for the identification of previous personal or familial venous thromboembolism

1 reference

12 December 2020

An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications

1 reference

12 December 2020

Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation

1 reference

12 December 2020

Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders

1 reference

12 December 2020

Hemorheologic considerations in the pathogenesis of vascular occlusive events in polycythemia vera

1 reference

12 December 2020

Mechanisms of bleeding and thrombosis in myeloproliferative disorders.

1 reference

12 December 2020

Relationships between thrombohemorrhagic complications and platelet function in patients with essential thrombocythaemia

1 reference

12 December 2020

Bleeding and thrombosis in the myeloproliferative disorders

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.E0316

1 reference

15 January 2018

Dimensions Publication ID

1052366116

0 references

1 reference

15 January 2018